Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,125 From $1,115
Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,125 From $1,115
杰富瑞将再生元制药的目标股价从1,115美元上调至1,125美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册